Our team of attorneys is familiar with clinical testing protocols and working with medical device companies as they move through their Phase I and Phase II trials, all the way through FDA approval, in addition to labeling and advertising issues. Our attorneys monitor and track FDA developments, as well as developments in the medical device industry, including mergers & acquisitions and divestitures.
We work with large and venture-backed medical device manufacturers to meet complex regulatory requirements, to manage the risks associated with the marketing and distribution of devices, and to defend against claims in litigation.
We help clients focus on avoiding litigation and adverse regulatory actions. When litigation or adverse government regulatory action arises, however, we aggressively assert and defend our clients’ interests in every appropriate forum.
News & Press Releases
- October 27, 2017